Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-20
DOI
10.1038/s41598-019-55372-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential country-level health and cost impacts of legalizing domestic sale of vaporized nicotine products
- (2019) Frederieke S. Petrović-van der Deen et al. EPIDEMIOLOGY
- Impact of tax and tobacco-free generation on health-adjusted life years in the Solomon Islands: a multistate life table simulation
- (2019) Ankur Singh et al. TOBACCO CONTROL
- Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering
- (2018) Eliano P. Navarese et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study
- (2018) Romana Pylypchuk et al. LANCET
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- Restricting tobacco sales to only pharmacies combined with cessation advice: a modelling study of the future smoking prevalence, health and cost impacts
- (2018) Frederieke S Petrović-van der Deen et al. TOBACCO CONTROL
- Statins for Primary Prevention of Cardiovascular Disease
- (2017) Dhruv S. Kazi et al. MEDICAL CLINICS OF NORTH AMERICA
- Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study
- (2017) Josh Knight et al. PLoS One
- Impact of five tobacco endgame strategies on future smoking prevalence, population health and health system costs: two modelling studies to inform the tobacco endgame
- (2017) Frederieke S van der Deen et al. TOBACCO CONTROL
- Impact of increasing tobacco taxes on working-age adults: short-term health gain, health equity and cost savings
- (2017) Christine L Cleghorn et al. TOBACCO CONTROL
- A national quitline service and its promotion in the mass media: modelling the health gain, health equity and cost–utility
- (2017) Nhung Nghiem et al. TOBACCO CONTROL
- Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
- (2017) Manon C. Stam‐Slob et al. Journal of the American Heart Association
- The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects
- (2016) Nhung Nghiem et al. BMC PUBLIC HEALTH
- Statins for Prevention of Cardiovascular Disease in Adults
- (2016) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tobacco retail outlet restrictions: health and cost impacts from multistate life-table modelling in a national population
- (2016) Amber L Pearson et al. TOBACCO CONTROL
- One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study (ANZACS-QI 8)
- (2015) Corina Grey et al. EUROPEAN HEART JOURNAL
- Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19)
- (2015) Sue Wells et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Modeling health gains and cost savings for ten dietary salt reduction targets
- (2015) Nick Wilson et al. Nutrition Journal
- Health and Economic Impacts of Eight Different Dietary Salt Reduction Interventions
- (2015) Nhung Nghiem et al. PLoS One
- Health, Health Inequality, and Cost Impacts of Annual Increases in Tobacco Tax: Multistate Life Table Modeling in New Zealand
- (2015) Tony Blakely et al. PLOS MEDICINE
- Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
- (2014) Ana Filipa Macedo et al. BMC Medicine
- Effects of blood pressure lowering on outcome incidence in hypertension
- (2014) Costas Thomopoulos et al. JOURNAL OF HYPERTENSION
- Relationships of different types of event to cardiovascular death in trials of antihypertensive treatment
- (2013) Antonella Zambon et al. JOURNAL OF HYPERTENSION
- When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
- (2013) Ferrán Catalá-López et al. PLoS One
- Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
- (2012) Linda J Cobiac et al. BMC PUBLIC HEALTH
- Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16
- (2012) Suneela Mehta et al. European Journal of Preventive Cardiology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation